Ang-(1–7) protects skeletal muscle function in aged mice
Open Access
- 21 September 2021
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 22 (1) , 1-8
Abstract
Background: The angiotensin-converting enzyme 2 (ACE2)/angiotensin 1–7 (Ang-(1–7)) axis has been shown to protect against the age-associated decline in skeletal muscle function. Here, we investigated the protective effects of ACE2 in mitigating the age-associated decline of skeletal muscle function and to identify the potential underlying molecular mechanisms.Methods: We measured the expression levels of Ang-(1–7) in C57BL/6J mice of different ages and correlated these levels with measures of skeletal muscle function. We also investigated the expression of myocyte enhancer factor 2 A (MEF2A) in ACE2 knockout (ACE2KO) mice and its relationship with muscle function. We then treated aged ACE2KO mice for four weeks with Ang-(1–7) and characterized the levels of MEF2A and skeletal muscle function before and after treatment. We assessed the impact of Ang-(1–7) on the growth and differentiation of C2C12 cells in vitro and assessed changes in expression of the glucose transporter type 4 (Glut4).Results: Aged mice showed reduced skeletal muscle function and levels of Ang-(1–7) expression in comparison to young and middle-aged mice. In ACE2KO mice, skeletal muscle function and MEF2A protein expression were significantly lower than in age-matched wild-type (WT) mice. After one month of Ang-(1–7) treatment, skeletal muscle function in the aged ACE2KO mice improved, while MEF2A protein expression was similar to that in the untreated group. In C2C12 cells, Ang-(1–7) was shown to promote along with the upregulated expression of Glut4.Conclusions: The ACE2/ Ang-(1–7) axis has a protective function in skeletal muscle and administration of exogenous Ang-(1–7) can delay the age-related decline in the function of skeletal muscle.Keywords
All Related Versions
Funding Information
- The National Natural Science Foundation of China (81501197, 81501197, 81501197, 81501197, 81501197, 81501197, 81501197)
- Sichuan Provincial Science and Technology Support Program (2019YFG0194, 2020YFG0086, 2019YFG0194, 2020YFG0086, 2019YFG0194, 2020YFG0086, 2019YFG0194, 2020YFG0086, 2019YFG0194, 2020YFG0086, 2019YFG0194, 2020YFG0086, 2019YFG0194, 2020YFG0086)
- National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University (Z20191010, Z20191010, Z20191010, Z20191010, Z20191010, Z20191010, Z20191010)
This publication has 29 references indexed in Scilit:
- Angiotensin 1–7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivoPeptides, 2014
- Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signallingHuman Molecular Genetics, 2013
- Exercise, GLUT4, and Skeletal Muscle Glucose UptakePhysiological Reviews, 2013
- Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in MiceDiabetes, 2012
- Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In VivoDiabetes, 2011
- Improved Lipid and Glucose Metabolism in Transgenic Rats With Increased Circulating Angiotensin-(1-7)Arteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Angiotensin II Type 1 and Type 2 Receptors Regulate Basal Skeletal Muscle Microvascular Volume and Glucose UseHypertension, 2010
- ACE-Inhibition and Physical Function: Results From the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) StudyJournal of the American Medical Directors Association, 2010
- Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axisHypertension Research, 2009
- Chronic infusion of angiotensin-(1–7) improves insulin resistance and hypertension induced by a high-fructose diet in ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2009